Fortis Healthcare Limited's Nomination & Remuneration Committee has approved a significant employee stock option grant under its Employee Stock Option Scheme 2026. The committee meeting, held on April 23, 2026, sanctioned the allocation of substantial equity-based compensation to eligible employees as part of the company's talent retention and incentive strategy.

Stock Option Grant Details

The committee approved the grant of 1,32,05,200 employee stock options to eligible employees under the Fortis Healthcare Limited Employee Stock Option Scheme 2026. Each option carries the right to acquire one fully paid-up equity share with a face value of ₹10.

Vesting and Exercise Framework

The stock options operate under a structured timeline designed to align employee interests with long-term company performance. The vesting schedule spans a maximum period of 3 years from the grant date, with specific conditions as determined by the Nomination & Remuneration Committee.

Regulatory Compliance and Scheme Structure

The Employee Stock Option Scheme 2026 operates in full compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The exercise price of ₹923.10 per option was determined based on the closing price on the recognized stock exchange with higher trading volume as of April 22, 2026.

Key features of the scheme include:

• Vesting subject to conditions approved by the Nomination & Remuneration Committee
• Exercise window commencing from vesting date
• Maximum exercise period of 4 years from each vesting milestone
• Compliance with current SEBI regulations for employee benefit schemes

Corporate Governance and Documentation

The grant follows the company's previous intimation dated February 13, 2026, and adheres to disclosure requirements under Regulation 30 of SEBI Listing Regulations. The complete scheme documentation has been made available on the company's website at www.fortishealthcare.com , ensuring transparency for stakeholders.

The approval represents a continuation of Fortis Healthcare's employee engagement strategy, utilizing equity-based compensation to attract and retain talent in the competitive healthcare sector. The substantial option grant reflects the company's commitment to aligning employee interests with shareholder value creation through long-term equity participation.

Fortis Healthcare Limited has formally announced its schedule for upcoming investor and analyst meetings through an official communication dated April 22, 2026. The healthcare company has informed both the National Stock Exchange of India and BSE Limited about the planned interactions with the investment community, providing detailed information about the comprehensive engagement program.

Official Communication and Regulatory Compliance

The announcement comes through official letter reference FHL/SEC/2026-27, signed by Company Secretary and Compliance Officer Satyendra Chauhan. The communication has been made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring proper disclosure to both major stock exchanges where the company's shares are listed.

Meeting Details and Schedule

The healthcare company has organized a comprehensive investor engagement program spanning two days in Mumbai. The meetings are structured as a non-deal roadshow organized by JM Financial, providing investors and analysts with insights into the company's operations and the broader healthcare industry landscape.

Meeting Focus and Information Disclosure

The investor meetings are designed to discuss general business updates and developments within the healthcare industry in which Fortis Healthcare operates. The company has specifically emphasized that no Unpublished Price Sensitive Information (UPSI) will be shared or discussed during the investor meetings, ensuring adherence to regulatory guidelines governing investor interactions and information disclosure.

The company has indicated that the schedule and timings remain subject to changes due to potential exigencies on the part of either investors or the company. The two-day format allows for extensive engagement with the investment community, providing opportunities for both individual discussions and group presentations while accommodating various investor preferences and requirements.